SCHEMBL8901747

SCHEMBL8901747

NCC1CCC(CNc2nc(NCCO)c3ccccc3n2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.56
HTT P42858 3/20 0.56
POLB P06746 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
RAD52 P43351 3/20 0.52
MAPT P10636 2/20 0.52
PGK1 P00558 1/20 0.52
GAA P10253 1/20 0.52
RECQL P46063 1/20 0.52
BLM P54132 1/20 0.52
KMT2A Q03164 3/20 0.51
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
SLC2A1 P11166 2/20 0.49
TLR7 Q9NYK1 1/20 0.49
APP P05067 1/20 0.49
MAPK1 P28482 1/20 0.49
MEN1 O00255 1/20 0.48
USP2 O75604 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8898278 0.91 SOS1 (0.52) RAD52MAPTKMT2AKDM4EALDH1A1
SCHEMBL8901739 0.87 TAAR1 (0.52) TAAR1HTTPOLBSMN1; SMN2RAD52
SCHEMBL8899155 0.86 TRIM58 (0.57) POLBRAD52KMT2AALDH1A1SLC2A1
SCHEMBL8907323 0.86 TRIM58 (0.57) POLBRAD52KMT2AALDH1A1SLC2A1
SCHEMBL8898526 0.85 CYP1A2 (0.50) MAPTKMT2AKDM4EALDH1A1TLR7
SCHEMBL8898947 0.85 TLR9 (0.51) POLBRAD52GAAALDH1A1TLR7
SCHEMBL8889922 0.84 NPY5R (0.49) RAD52MAPTALDH1A1TLR7APP
SCHEMBL8890983 0.84 TLR7 (0.45) RAD52MAPTALDH1A1TLR7APP
SCHEMBL8890083 0.84 POLB (0.55) POLBGAASLC2A1APPSOS1
SCHEMBL8908343 0.84 POLB (0.55) POLBGAASLC2A1APPSOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020823-A2 2-AMINO QUINAZOLINE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS NOVARTIS AG (CH) 1997-06-12 WO disclosed